Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery.
about
Systemic delivery to central nervous system by engineered PLGA nanoparticlesInfluence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene deliveryBiomedical Applications of Biodegradable Polymers.Polymeric Materials for Gene Delivery and DNA VaccinationLigand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.Dendritic cell-based human immunodeficiency virus vaccine.Amphiphilic and biodegradable methoxy polyethylene glycol-block-(polycaprolactone-graft-poly(2-(dimethylamino)ethyl methacrylate)) as an effective gene carrier.Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applicationsSingle-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.Acid-degradable cationic dextran particles for the delivery of siRNA therapeutics.Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters).Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradationSurface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.Nanoparticulate systems for polynucleotide delivery.Hydrophobic Effects in the Critical Destabilization and Release Dynamics of Degradable Multilayer Films.The pros and cons of polyelectrolyte capsules in drug delivery.Cationic nanoparticles for cancer therapy.Biomimetic Extracellular Environment Based on Natural Origin Polyelectrolyte Multilayers.Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.Hydrolytic cationic ester microparticles for highly efficient DNA vaccine delivery.Hyaluronic acid/poly(β-amino ester) polymer nanogels for cancer-cell-specific NIR fluorescence switch.Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine).In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta -aminoester)-graft-PEG for cancer chemotherapy.A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices.Dual Stimuli-Responsive Poly(β-amino ester) Nanoparticles for On-Demand Burst Release.Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.Optimization of release pattern of FGF-2 and BMP-2 for osteogenic differentiation of low-population density hMSCs.Preparation and characterization of novel PBAE/PLGA polymer blend microparticles for DNA vaccine delivery.
P2860
Q26751294-7B4CC448-D0D3-4FA1-99E2-8C3989CF22D3Q28817429-A965A847-228A-4F59-B229-9FD09F5A9317Q30426452-5F429DFB-8DBC-43BE-86E6-CDCB7D116D44Q33565296-75FF8339-C996-4A23-A518-BC40C1968715Q33761970-EE19D39A-67AC-4A79-83BE-C67386456DD9Q33874652-44D3E9E4-6864-4391-8BC3-1AA6DBA1D925Q34591849-5D15282E-9D3B-4BF7-BAFB-20ADB7549A4DQ34796662-2E08A8FF-F394-4A7A-AF01-94B8F3DE79B9Q35097053-BC086363-5832-4065-A19E-3E251C7F58F4Q35155064-5183FAF6-2E69-4608-BE78-95F233300E1DQ36047076-37DACCB8-FC5B-40A3-BD57-CE17F598B1F7Q36122915-6D073321-7429-4EAE-8B85-D1C2AD740F4CQ36225449-66354FCB-06E8-4C14-B27F-FE79F8D88FCBQ36581724-16B3700F-6340-4B2E-B647-1F08FE15826EQ36763633-D5488D3A-D01A-41AC-908C-FDCB979A3980Q37004107-FAE8644D-825B-4363-9CEE-6A3333E5EB46Q37234817-4185F8FE-9A27-4362-9535-74D32D57211CQ37515447-EAB0AFCB-9FB0-423A-AB58-828F65902EDFQ37743515-0A16623B-48C0-4DFD-B8B1-E18A6D73ED9DQ38902524-7FC9BD35-B391-47F4-BD0F-3B65DA73950FQ38994544-54974DBD-4533-43CA-80C1-641FC832B5CEQ39153853-80D56285-0515-4DE1-8BAD-2AEB70641B2EQ39321264-B7E99517-1936-4B14-BFE3-F39B3FBE41D5Q39421763-B10F4796-A49E-449D-AE4C-3ED108594E3EQ39574217-B2CBB753-2AE6-4CA3-B59F-34AEFEB83948Q40110955-646DF8FA-D694-4AEB-BE7C-69980491F20AQ40362968-A7F0222E-6D9A-46A3-AFA1-AB22C4E73FF4Q50270905-3CC9F394-A7CB-456D-A5A0-37938BC0A2A2Q51567300-A455CEF7-0456-4150-BFD8-073B809290DCQ53061912-0652D21E-D2BF-4A74-B972-6AFE7965068AQ53391578-08144400-A8B5-4375-82F9-5A572AEA11BC
P2860
Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Formulation and characterizati ...... for genetic vaccine delivery.
@en
type
label
Formulation and characterizati ...... for genetic vaccine delivery.
@en
prefLabel
Formulation and characterizati ...... for genetic vaccine delivery.
@en
P2093
P1476
Formulation and characterizati ...... s for genetic vaccine delivery
@en
P2093
David M Lynn
Robert Langer
Sidharth V Puram
P304
P356
10.1016/J.JCONREL.2005.04.022
P407
P577
2005-10-01T00:00:00Z